Plasma sphingolipids and risk of cardiovascular diseases: a large-scale lipidomic analysis.

Jowy Yi Hoong SeahWee Siong ChewFederico TortaChin Meng KhooMarkus R WenkDeron R HerrHyungwon ChoiE Shyong TaiRob M van Dam

Published in: Metabolomics : Official journal of the Metabolomic Society (2020)

Our results do not support the hypothesis that higher ceramide concentrations are linked to higher CVD risk, but suggest that other classes of sphingolipids may affect CVD risk.

Keyphrases

cardiovascular disease
type diabetes
coronary artery disease
cardiovascular risk factors
cardiovascular events